NASDAQ:BMEA

Biomea Fusion Stock Predictions

etoro logo Buy BMEA
*Your capital is at risk
$1.30
-0.0700 (-5.11%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BMEA Prediction Chart

BMEA Predictions History

Latest community submissions for BMEA.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 31, 2024 $40.00 +930.93% Unrealistic Excluded from avg $3.88 X 0.00% 0
Oct 21, 2024 $11.29 -3.11% $11.24 V 99.58% 5
Oct 21, 2024 $11.42 -1.94% $11.24 V 98.37% 1
Oct 21, 2024 Bullish $11.24 X 0
Jan 2, 2024 $15.28 +5.23% $14.67 V 95.85% 1
Jan 2, 2024 $14.05 -3.27% $14.67 X 95.74% 0
Jan 2, 2024 Bearish $14.67 X 0
Jul 7, 2023 Bullish $21.91 V 1
May 16, 2023 Bullish $32.89 X 0
May 16, 2023 $32.97 -2.91% $32.89 V 99.75% 6
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BMEA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOMEA FUSION, INC.
Biomea Fusion
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in R...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE